The increased NSE levels were associated with the extent of organ involvement and OCS use and changed in accordance with the patients' disease status, indicating that NSE may be useful for predicting the use of OCS and monitoring sarcoidosis status. This evidence concerns the gene ENO2 and sarcoidosis.